News from neurocrine biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 20, 2014, 16:05 ET

Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has initiated a Phase III clinical trial (Kinect 3 Study) of its...

Oct 02, 2014, 16:02 ET

Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has initiated a clinical trial of NBI-98854, a proprietary small molecule...

Oct 01, 2014, 17:20 ET

Neurocrine Biosciences, Inc. Announces Appointment of Malcolm Lloyd-Smith as Chief Regulatory Officer

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Malcolm Lloyd-Smith has joined the executive management team as Chief Regulatory...

Sep 03, 2014, 13:00 ET

Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Aug 06, 2014, 16:02 ET

Neurocrine Biosciences Reports Second Quarter 2014 Results

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended June 30, 2014.  For the second quarter...

Jul 29, 2014, 10:00 ET

Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2014 financial results...

Jun 11, 2014, 07:00 ET

Neurocrine Biosciences Presenting NBI-98854 Scientific Abstracts And Posters At The International Parkinson And Movement Disorder Society's 18th Annual Congress

 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that on June 11, 2014, two scientific posters associated with its study of...

May 29, 2014, 13:00 ET

Neurocrine Biosciences To Present At The Jefferies 2014 Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

May 08, 2014, 13:00 ET

Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

May 01, 2014, 13:00 ET

Neurocrine Biosciences to Present at Deutsche Bank's 39th Annual Health Care Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Apr 30, 2014, 16:01 ET

Neurocrine Biosciences Reports First Quarter 2014 Results

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended March 31, 2014.  For the first quarter...

Apr 25, 2014, 15:30 ET

Neurocrine Biosciences Announces Conference Call And Webcast To Report First Quarter 2014 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2014 financial results after the Nasdaq...

Mar 04, 2014, 14:00 ET

Neurocrine Biosciences To Present At The 26th Annual Roth Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Feb 27, 2014, 19:00 ET

Neurocrine Biosciences To Present At The Cowen And Company 34th Annual Health Care Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Feb 26, 2014, 21:12 ET

Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the pricing of an underwritten public offering of 8,000,000 shares of its...

Feb 25, 2014, 16:00 ET

Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it is offering to sell 7,000,000 shares of its common stock in an underwritten...

Feb 25, 2014, 07:30 ET

Neurocrine Biosciences Announces NBI-98854 Scientific Presentations at the International Parkinson and Movement Disorder Society's 18th Annual Congress

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that two NBI-98854 scientific abstracts have been accepted for the scientific program at...

Feb 07, 2014, 10:00 ET

Neurocrine Biosciences To Present At The Leerink Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin, Chief Financial Officer of Neurocrine Biosciences, will be...

Feb 06, 2014, 16:01 ET

Neurocrine Biosciences Reports Fourth Quarter And Year End 2013 Results

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter and year ended December 31, 2013. For the...

Feb 04, 2014, 09:20 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2013 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its fourth quarter and year-end 2013 financial results...